Anti-CD154 mAb Treatment But Not Recipient CD154 Deficiency Leads to Long-Term Survival of Xenogeneic Islet Grafts
Open Access
- 5 April 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (5) , 1021-1031
- https://doi.org/10.1111/j.1600-6143.2005.00795.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- HIGH-DOSE PORCINE HEMATOPOIETIC CELL TRANSPLANTATION COMBINED WITH CD40 LIGAND BLOCKADE IN BABOONS PREVENTS AN INDUCED ANTI-PIG HUMORAL RESPONSETransplantation, 2000
- Xenotransplantation - state of the art - Update 1999Frontiers in Bioscience-Landmark, 1999
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infectionImmunity, 1994
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992